1. Yang, Xinyi, Zheng, Xu, Zhu, Yuqi, Zhao, Ping, Zhu, Huanzhang. 2024. Asialoglycoprotein receptor 1 promotes SARS-CoV-2 infection of human normal hepatocytes. In Signal transduction and targeted therapy, 9, 42. doi:10.1038/s41392-024-01754-y. https://pubmed.ncbi.nlm.nih.gov/38355848/
2. Svecla, Monika, Da Dalt, Lorenzo, Moregola, Annalisa, Bonacina, Fabrizia, Norata, Giuseppe Danilo. 2024. ASGR1 deficiency diverts lipids toward adipose tissue but results in liver damage during obesity. In Cardiovascular diabetology, 23, 42. doi:10.1186/s12933-023-02099-6. https://pubmed.ncbi.nlm.nih.gov/38281933/
3. Svecla, Monika, Moregola, Annalisa, Dalt, Lorenzo Da, Bonacina, Fabrizia, Norata, Giuseppe Danilo. 2024. ASGR1 deficiency improves atherosclerosis but alters liver metabolism in ApoE-/- mice. In Cardiovascular diabetology, 23, 428. doi:10.1186/s12933-024-02507-5. https://pubmed.ncbi.nlm.nih.gov/39616371/
4. Yu, Xiaorui, Tao, Jiawang, Wu, Yuhang, Xu, Yingying, Li, Yin-Xiong. 2024. Deficiency of ASGR1 Alleviates Diet-Induced Systemic Insulin Resistance via Improved Hepatic Insulin Sensitivity. In Diabetes & metabolism journal, 48, 802-815. doi:10.4093/dmj.2023.0124. https://pubmed.ncbi.nlm.nih.gov/38310881/
5. Nioi, Paul, Sigurdsson, Asgeir, Thorleifsson, Gudmar, Thorsteinsdottir, Unnur, Stefansson, Kari. 2016. Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease. In The New England journal of medicine, 374, 2131-41. doi:10.1056/NEJMoa1508419. https://pubmed.ncbi.nlm.nih.gov/27192541/